Page last updated: 2024-12-08
ly 79771
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
LY 79771: lipolytic cpd for weight control; RN given refers to HCl(R-(R*,S*))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 173269 |
| MeSH ID | M0103219 |
Synonyms (16)
| Synonym |
|---|
| ly 79771 |
| gw48v1582z , |
| 74248-92-3 |
| benzenemethanol, alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, hydrochloride, (r-(r*,s*))- |
| ly-79771 |
| (r-(r*,s*))-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol |
| unii-gw48v1582z |
| ly 79730 |
| lilly 79771 |
| benzenemethanol, .alpha.-((((1s)-3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)-, hydrochloride (1:1), (.alpha.r)- |
| 4-{3-[(2-hydroxy-2-phenylethyl)amino]butyl}phenol--hydrogen chloride (1/1) |
| DTXSID60995761 |
| Q27279313 |
| 4-[(3s)-3-[[(2r)-2-hydroxy-2-phenylethyl]amino]butyl]phenol;hydrochloride |
| benzenemethanol, alpha-[[[(1s)-3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride (1:1), (alphar)- |
| AKOS040748825 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.26
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.26) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||